Back to Search Start Over

Targeting PDAC metabolism: Environment determines what has GOT2 give.

Authors :
Newsom OJ
Sullivan LB
Source :
Cell metabolism [Cell Metab] 2022 Nov 01; Vol. 34 (11), pp. 1617-1619.
Publication Year :
2022

Abstract

Metabolic disruption is a mainstay of cancer therapy, prompting research aimed at identifying novel metabolic targets. Despite strong effects observed in culture, three recent studies found pancreatic tumors are refractory to disruption of the metabolic enzyme GOT2, revealing complex interactions within the tumor microenvironment that bypass its conventional metabolic roles.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1932-7420
Volume :
34
Issue :
11
Database :
MEDLINE
Journal :
Cell metabolism
Publication Type :
Academic Journal
Accession number :
36323232
Full Text :
https://doi.org/10.1016/j.cmet.2022.09.027